A multiscale map of the stem cell state in pancreatic adenocarcinoma NK Lytle, LP Ferguson, N Rajbhandari, K Gilroy, RG Fox, A Deshpande, ... Cell 177 (3), 572-586. e22, 2019 | 142 | 2019 |
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer W Lin, N Rajbhandari, C Liu, K Sakamoto, Q Zhang, AA Triplett, SK Batra, ... Cancer research 73 (6), 1821-1830, 2013 | 84 | 2013 |
A prevalence of thyroid dysfunction in Kathmandu University Hospital, Nepal M Aryal, P Gyawali, N Rajbhandari, P Aryal, D Raj Biomedical Research 21 (4), 2010 | 80 | 2010 |
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers N Rajbhandari, WC Lin, W Barbara, T Aleata, W Kay-Uwe. Cell Reports 18 (9), 2243-2255, 2017 | 58 | 2017 |
Genomic and epigenomic landscaping defines new therapeutic targets for adenosquamous carcinoma of the pancreas E Lenkiewicz, S Malasi, TL Hogenson, LF Flores, W Barham, WJ Phillips, ... Cancer research 80 (20), 4324-4334, 2020 | 47 | 2020 |
Janus kinase 1 is essential for inflammatory cytokine signaling and mammary gland remodeling K Sakamoto, BL Wehde, KH Yoo, T Kim, N Rajbhandari, HY Shin, ... Molecular and cellular biology 36 (11), 1673-1690, 2016 | 39 | 2016 |
Cancer Cell Dormancy in Novel Mouse Models for Reversible Pancreatic Cancer: A Lingering Challenge in the Development of Targeted Therapies L Wan-Chi, N Rajbhandari, KU Wagner Cancer Research, 2014 | 35 | 2014 |
Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal M Sigdel, N Rajbhandari, S Basnet, A Nagila, P Basnet, T Basanta Nepal Medical College Journal 10 (4), 242-245, 2008 | 30 | 2008 |
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma LP Ferguson, J Gatchalian, ML McDermott, M Nakamura, K Chambers, ... Nature Communications 14 (1), 292, 2023 | 10 | 2023 |
Repurposing HDAC and mTOR inhibitors for pancreatic cancer. M Biermann, C Quintero, P Ferguson, N Rajbhandari, DE Park, H Patel, ... Journal of Clinical Oncology 40 (16_suppl), e16234-e16234, 2022 | 3 | 2022 |
Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer N Rajbhandari, M Hamilton, CM Quintero, LP Ferguson, R Fox, ... Cancer cell 41 (11), 1989-2005. e9, 2023 | 2 | 2023 |
Department of Biochemistry M Aryal, P Gyawali, N Rajbhandari, P Aryal, DR Pandeya Kathmandu University School of Medical Sciences/Dhulikhel Hospital-Kathmandu …, 2010 | 2 | 2010 |
The Janus kinase 1 is critical for pancreatic cancer initiation and progression H Shrestha, PD Rädler, R Dennaoui, MN Wicker, N Rajbhandari, Y Sun, ... Cell Reports 43 (5), 2024 | 1 | 2024 |
Imaging Approaches in Cancer Biology N Rajbhandari, E Diaz, M Kritzik, T Reya Cold Spring Harbor Perspectives in Medicine, a041349, 2024 | | 2024 |
Abstract PR13: Single-cell mapping reveals a common origin for diverse subtypes of pancreatic cancer N Rajbhandari, M Hamilton, T Reya Cancer Research 84 (2_Supplement), PR13-PR13, 2024 | | 2024 |
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi AG Barber, CM Quintero, M Hamilton, N Rajbhandari, R Sasik, Y Zhang, ... bioRxiv, 2024.04. 11.589053, 2024 | | 2024 |
Tracing tumor evolution and subtype specification in pancreatic cancer N Rajbhandari, M Hamilton, C Quintero, LP Ferguson, R Fox, CM Schurch, ... | | 2021 |
Abstract PO-036: Defining the role of chromatin remodelers in pancreatic cancer LP Ferguson, J Gatchalian, N Lytle, N Rajbhandari, M McDermott, ... Cancer Research 80 (22_Supplement), PO-036-PO-036, 2020 | | 2020 |
Abstract PO-043: Interception of pancreatic cancer progression ML McDermott, LP Ferguson, K Chambers, N Rajbhandari, T Reya Cancer Research 80 (22_Supplement), PO-043-PO-043, 2020 | | 2020 |
Abstract B18: Defining the role of chromatin remodeling complexes in pancreatic cancer stem cells LP Ferguson, J Gatchalian, NK Lytle, N Rajbhandari, K Chambers, ... Cancer Research 79 (24_Supplement), B18-B18, 2019 | | 2019 |